BMC Neurology (Oct 2010)

Neuroprotective properties of levosimendan in an in vitro model of traumatic brain injury

  • Rossaint Rolf,
  • Weis Joachim,
  • Rossaint Jan,
  • Loetscher Philipp D,
  • Hein Marc,
  • Roehl Anna B,
  • Coburn Mark

DOI
https://doi.org/10.1186/1471-2377-10-97
Journal volume & issue
Vol. 10, no. 1
p. 97

Abstract

Read online

Abstract Background We investigated the neuroprotective properties of levosimendan, a novel inodilator, in an in vitro model of traumatic brain injury. Methods Organotypic hippocampal brain slices from mouse pups were subjected to a focal mechanical trauma. Slices were treated after the injury with three different concentrations of levosimendan (0.001, 0.01 and 0.1 μM) and compared to vehicle-treated slices. After 72 hrs, the trauma was quantified using propidium iodide to mark the injured cells. Results A significant dose-dependent reduction of both total and secondary tissue injury was observed in cells treated with either 0.01 or 0.1 μM levosimendan compared to vehicle-treated slices. Conclusion Levosimendan represents a promising new pharmacological tool for neuroprotection after brain injury and warrants further investigation in an in vivo model.